The report "Vaccine Adjuvants Market by Product (Mineral Salt-based Adjuvant, Tensoactive Adjuvants, Adjuvant Emulsions, Liposome Adjuvants, Carbohydrate Adjuvants, Bacteria-derived Adjuvants, Virus-like Particles (VLP), Others), by Usage (Active Immunostimulants, Carriers, Vehicle Adjuvants), by Disease Type (Infectious Disease, Cancer), by Application (Research Applications, Commercial Applications) - Global Forecasts to 2030" The global vaccine adjuvants market is projected to reach USD 1.53 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 12.6% during the forecast period 2024-2030. The growth of the market is majorly driven by the increasing use of recombinant subunit and synthetic vaccines. The market for vaccine adjuvants plays a crucial role in the healthcare sector. This has grown and changed significantly in recent years due to the increased demand for vaccines that are long-lasting and effective. Adding adjuvant substances to vaccines to boost the immune response is crucial to increasing the overall effectiveness of vaccinations. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=17173 Competitive Dashboard: The prominent key players operating in the global Vaccine Adjuvants market are 3M (U.S.), Agenus Inc. (U.S.), Abbott (U.S.), Adjuvatis (France), Astellas Pharma Inc. (Japan), Astrazeneca (U.K.), Bavarian Nordic (Denmark), CureVac AG (Germany), Croda International Plc (U.K.), CSL Limited, Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), Merck KGaA (Germany), Novavax, Inc. (U.S.), InvivoGen (France), SPI Pharma (U.S.), Phibro Animal Health Corporation. (U.S.), SEPPIC (France), OZ Biosciences (France), Kineta, Inc. (U.S.), vaxine (Australia) Regional Overview: The report also examines the current concerns and their Future Effects on the vaccine adjuvants market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the vaccine adjuvants market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.
- North America (U.S., Canada)
- Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
- Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
- Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
- The vaccine adjuvants market research report includes historical data, trending features, and market growth estimates for the future.
- The qualitative and quantitative analysis of the market along with CAGR calculation for the forecast period.
- The market report helps to provide the best results for business enhancement and business growth.
- The report gives a comprehensive overview of both primary and secondary data.
- The vaccine adjuvants market key players covered here to help them strengthen their place in the market.